THE BUSINESS OF BIOTECH
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch
As if Orna Therapeutics' CEO, Thomas Barnes, isn't enough to draw you in to the Business of Biotech, we teamed up with Advancing RNA Editorial & Community Director Anna Rose Welch to co-host this week's episode. Together, Anna Rose and I press Dr. Barnes on his transition from academia to biotech, the therapeutic proposition of circular, or "O", RNA and why it holds great potential to best linear RNA constructs, the novel, platform- and partnership-based approaches Orna is taking to address B-cell lymphomas and Duchenne Muscular Dystrophy, viral vector and lipid nanoparticle complexity, and a whole lot more.
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Thomas Barnes
Rahul Kakkar
Bobby Reddy
Jason Gardner
Karen Harris
Michael Nally
Gavin Samuels
Robert Williamson
Brian Finrow
Jack Hoppin
MEET THE HOST
Hosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.
Interested in joining us on air ? Contact us
RECENT EPISODES
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, Ph.D.
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.
Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
FINANCE & CAPITAL MARKETS
CDMO + Emerging Bio Partnership With Forge's John Maslowski And Ray's Jenny Holt
Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. And Parag Shah
Athersys' Ivor Macleod On Bringing Big-League Financial Experience To An Emerging Biotech
DISCOVERY
Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius
Genetic Testing & Neurodegenerative Disorders With AviadoBio's Lisa Deschamps
Oligonucleotide Opportunities in DMD with PepGen's James McArthur, Ph.D.
REGULATORY
Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
How To Apply For BTD And Win It With Drs. Ira Gupta & Shanthi Ganeshan
MANUFACTURING
Regenerative Wound Care With BioStem Technologies' Jason Matuszewski & Andrew VanVurst
Complete CAR T Manufacturing Control with Cellectis' Steve Doares
Inflammation & Antibodies With Ampio Pharmaceutical's Mike Martino, CEO
Commercial Readiness with Orca Bio's Dan Kirby
CMC Developability Assessments For Rapid Ph.1 Entry With AltruBio's Gene Lee, Ph.D.
CDMO With A Pipeline Featuring Forge Biologics President & CEO Dr. Timothy J. Miller
Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells
Gene Therapy Manufacturing Advances With Aruvant CTO Dr. Palani Palaniappan
A Scale-Up Story With Solis BioDyne Drs. Kadri Artma And Angela Vaasa
Propagating Peptides With Peptilogics' Jonathan Steckbeck, Ph.D.